EGFR and prostate cancer: MicroT-CDS prediction identified the top five most significant KEGG pathways: ErbB signaling pathway (p = 2.3x10-26, 14 miRNAs), prostate cancer (p = 2.3x10–26, 14 miRNAs), TGF-beta signaling pathway (p = 2.1x10-25, 13 miRNAs), mitogen-activated protein kinase (MAPK) signaling pathways (p = 6.2x10-49, 24 miRNAs), and Pathways in cancer (p = 5.1x10-21, 16 miRNAs) (S6 Fig).